Fuchs Endothelial Dystrophy

HomeFuchs Endothelial Dystrophy
Our focus at The Medical Eye Clinic lies in the specialized field of Corneal care. Fuchs Endothelial Dystrophy is a debilitating condition characterized by the gradual loss of endothelial cells on the posterior surface of the cornea. These cells play a crucial role in maintaining corneal clarity, and their depletion leads to the accumulation of fluid within the cornea, resulting in impaired transparency. Descemet’s Stripping Automated Endothelial Keratoplasty is a minimally invasive surgical technique that offers swift restoration of visual function for individuals affected by this condition.
Fuchs Endothelial Dystrophy

What is Fuchs Endothelial Dystrophy?
  

Fuchs’ dystrophy, also recognized as Fuchs’ endothelial dystrophy, is a commonly inherited condition characterized by the gradual deterioration of the cornea. This ocular disease typically impacts both eyes and has a slightly higher prevalence among women compared to men. While early signs of Fuchs’ dystrophy may be observable in individuals in their 30s and 40s, visual impairment typically does not manifest until individuals reach their 50s and 60s.

The pathogenesis of Fuchs’ dystrophy involves the loss of endothelial cells, which are responsible for regulating corneal hydration. The absence of these cells leads to corneal edema, worsened upon waking due to limited fluid evaporation during sleep. Symptoms are most pronounced in the morning and gradually improve throughout the day, with duration of visual recovery lengthening as the disease progresses. Ultimately, irreversible vision loss may occur, necessitating a corneal transplant for restoration of visual acuity.